Genprex, Inc (GNPX) Stock Price

2.08 ▼ -0.13 (-5.88%)
Open: 2.26 Vol: 11.44K Day's range: 2.06 - 2.26 Nov 13, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
GNPX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 2.12▼ 2.11▼ 2.12▼ 2.15▼ 2.06▲
MA10 2.19▼ 2.19▼ 2.19▼ 2.16▼ 2.57▼
MA20 2.16▼ 2.16▼ 2.16▼ 2.08▼ 3.40▼
MA50 2.14▼ 2.17▼ 2.19▼ 2.65▼ 2.36▼
MA100 2.20▼ 2.11▼ 2.09▲ 3.28▼ 9.41▼
MA200 2.11▼ 2.22▼ 2.43▼ 2.33▼ 399.81▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.017▼ -0.014▼ -0.013▼ 0.054▲ -0.156▼
RSI 41.841▼ 42.336▼ 43.211▼ 41.506▼ 43.567▼
STOCH 11.474▼ 15.293▼ 16.667▼ 51.508     9.800▼
WILL %R -94.915▼ -94.915▼ -94.915▼ -44.776     -89.510▼
CCI -95.238     -82.842     -71.488     3.261     -80.741    
Latest Filters Detected On GNPX
MA $GNPX Price Crossed Below MA(26) Set Alert
MA $GNPX Price Crossed Below MA(13) Set Alert
MA $GNPX Price Crossed Below MA(7) Set Alert
▲ GAP $GNPX Open Gap Up %2 Set Alert
Genprex, Inc News
Genprex to Highlight Dual Delivery Strategy for Diabetes Gene Therapy at Future of Cell and Gene Therapy Symposium
Wednesday, November 11, 2026 04:00 AM
Genprex Senior Director of Quality Control & Product Development to Present Insights from Parallel AAV and Lipid-Based Development Programs. Presentation to Highlight Drug Develop ...
Genprex Presents Data Showing Reqorsa® Gene Therapy Activates Cellular Repair and Maintenance Programs Linked to Aging Biology in Patients, Supporting TUSC2 as a Key Regulator ...
Thursday, November 05, 2026 04:00 AM
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage biotechnology company developing gene therapies designed to restore tumor-suppressor function in cancer and ...
Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting
Wednesday, October 28, 2026 05:00 AM
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage biotechnology company developing gene therapies designed to ...
GNPX historical stock data
date open high low close volume
13/11/26 2.26 2.26 2.06 2.08 11,436
12/11/26 2.30 2.30 2.20 2.21 18,806
11/11/26 2.11 2.38 2.11 2.29 158,649
10/11/26 2.10 2.20 2.07 2.09 156,763
09/11/26 2.07 2.155 2.05 2.06 86,305
06/11/26 2.11 2.13 2.02 2.07 100,092
05/11/26 2.25 2.25 1.9501 2.10 196,222
04/11/26 2.35 2.35 2.14 2.14 244,300
03/11/26 2.24 2.38 2.24 2.31 142,047
02/11/26 2.33 2.3677 2.159 2.23 243,416
Quote Details
52wk Low:0.423
52wk High:9.99
Vol:11.44K
Avg Vol(3m):3.2M
1Y Chng:-24.09%
1M Chng:-23.53%
Add to Watch List
More Information
Index US Composite
Market Cap. 1.81M